Fagiolini, Andrea http://orcid.org/0000-0001-5827-0853
Alcalá, José Ángel
Aubel, Thomas
Bienkiewicz, Wojciech
Bogren, Mats Magnus Knut
Gago, Joaquim
Cerveri, Giancarlo
Colla, Michael
Sanchez, Francisco Collazos
Cuomo, Alessandro
Helge, Frieling
Iacoponi, Eduardo
Karlsson, Per-Axel
Peddu, Pradeep
Pettorruso, Mauro
Pereira, Henrique Jorge Ramos
Schölin, Johan Sahlsten
Vernaleken, Ingo Bernd
Funding for this research was provided by:
Recordati Pharmaceuticals
Article History
Received: 21 July 2020
Accepted: 17 September 2020
First Online: 26 September 2020
Competing interests
: AF is/has been a consultant and/or a speaker and/or has received research grants from Allergan, Angelini, Apsen, Boheringer Ingelheim, Daiichi Sankyo Brasil Farmacêutica, Doc Generici, FB-Health, Italfarmaco, Janssen, Lundbeck, Mylan, Otsuka, Pfizer, Recordati, Sanofi Aventis, Sunovion, Vifor; JAA has been a speaker for Adamed, Angelini, Casen Recordati, Lundbeck, Janssen-Cilag, Pfizer and Servier and an advisor to Lundbeck, Janssen-Cilag and Servier; TA has given lectures and participated in Advisory Boards for Janssen-Cilag, Otsuka, Recordati, Servier, Lilly; WB has reported no conflicts of interest; MNKB has been a consultant and speaker for Lundbeck, Otsuka and Recordati; JG has been an occasional speaker for Lundbeck, Janssen, Jaba-Recordati, Angelini; GC has been a speaker for Recordati, Janssen Cilag, Lundbeck, Doc Generici; MC TBA; FCS has received honoraria from the following companies for presentations fees and travel grants from Casen Recordati, Lundbeck-Otsuka, Janssen; AC is/has been a consultant and/or a speaker for Angelini, Apsen, Lundbeck, Otsuka, Pfizer; HF has received speaker and consultant honoraria (last 3 years) from Recordati, Servier, Janssen-Cilag; EI has acted as a consultant for Recordati; P-A K has given lectures for Eli Lilly, Janssen, Recordati, Lundbeck, Astra Zeneca, was involved in conducting safety studies for Janssen, Eli Lilly and took part in Advisory boards for Recordati and Eli Lilly; PP has been a speaker and/or consultant and/or received grants from Astra Zeneca, Janssen, Lundbeck, Recordati, Sunovion, Servier; MP has reported no conflicts of interest; HJRP has reported no conflicts of interest; JSS has given talks for Recordati and his employer Sahlgrenska University Hospital Gothenburg; IBV has given lectures for Recordati, Janssen, Neuraxpharm and Otsuka.